Amryt Pharma Plc (AMYT) Return on Investment ROI from the fourth quarter of 2021 to fourth quarter of and for the year 2021, average high and low, overall ranking from Dec 31 2021 to - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Amryt Pharma Plc  (NASDAQ: AMYT)


Amryt Pharma Plc's ROI from its fourth quarter of 2021 to the fourth quarter of and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Amryt Pharma Plc's ROI in the fourth quarter of 2021?


Within the Healthcare sector 263 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the third quarter of 2021 from 0 to 3303.

Definition and Formula of Return on Investment


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Investment (Dec 31 2021)
IV. Quarter		 0
III. Quarter		 0
II. Quarter		 0
I. Quarter
Y / Y Investment Change TTM 870.47 % 1341.57 % - - -
Y / Y Net Income Change TTM - - - - -
Investment (TTM) in Millions 378 659 659 659 99
Return On Investment (TTM) 0 % 0 % 0 % 0 % 0 %
AMYT's Overall Ranking # 3303 # 0 # 0 # 0 #
Seq. Investment Change TTM 13.48 % 33 % 73.08 % 271.5 % 68.57 %
Seq. Net Income Change TTM - - - - -
Net Income (TTM) in Millions 0 0 0 0 0

AMYT Company Profile >> Back to AMYT Roi Comparisons >> See Annual AMYT Return On Investment



Return On Investment AMYT's Ranking
Within: No.
Industry # 90
Sector # 264
Overall # 3303

Return On Investment Statistics
High Average Low
0.2 %
0.2 %
0.2 %
(Dec 31 2021)  







Financial Statements
Amryt Pharma Plc's IV. Quarter Investments $ 378 Millions AMYT's Balance sheet
Amryt Pharma Plc's IV. Quarter Income $ 0 Millions Quarterly AMYT's Income Statement
AMYT's Income by Division See AMYT's Income by Division


AMYT Annual Return On Investment (Dec 31 2021)
2021		 (Dec 31 2020)
2020


Total Investments in Millions 378 99 0 0 0
Y / Y Investment Growth 283.45 % - - - -
Net Income in Millions 1 -105 0 0 0
Y / Y Net Income Growth - - - - -
Annual Return On Investment 0.26 % -105.9 % - - -


Annual Roi Comment
In the fiscal year 2021 ROI improved to 0.26 % compared to the prior year, due to net income growth.

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
AMYT's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for AMYT's Competitors
Subscribers only: Roi for Amryt Pharma Plc's Suppliers
Subscribers only: Return On Investment for AMYT's Customers

Other Ratios
AMYT's Roa AMYT's Inventory Turnover Ratio AMYT's Growth Rates AMYT's Dividend Statistics
AMYT's Profitability Ratios AMYT's Asset Turnover Ratio AMYT's Dividend Growth
AMYT's Roe AMYT's Valuation Ratios AMYT's Financial Strength Ratios AMYT's Dividend Payout Ratio



Companies with similar Return On Investment at Dec 31 2021, within Healthcare Sector ROI

Date modified: 2023-03-22T13:18:58+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.